中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
8期
112-112,113
,共2页
肾康注射液%慢性肾功能衰竭%肾性贫血%疗效
腎康註射液%慢性腎功能衰竭%腎性貧血%療效
신강주사액%만성신공능쇠갈%신성빈혈%료효
Shenkang Injection%chronic renal failure%renal anemia%curative effect
目的：观察肾康注射液治疗慢性肾功能衰竭( CRF )并肾性贫血的临床疗效。方法将60例慢性肾功能衰竭并肾性贫血患者随机分为治疗组和对照组，各30例，均给予重组人促红细胞生成素（rHuEPO）注射液及口服铁剂等治疗，治疗组加用肾康注射液。观察两组治疗前后血红蛋白（Hb）、血细胞比容（Hct）、血清肌酐（SCr）、血尿素氮（BUN）等指标的变化情况。结果治疗组的肾性贫血和肾功能指标改善均明显优于对照组（ P＜0.05）。结论肾康注射液治疗慢性肾功能衰竭并肾性贫血，疗效显著，值得临床推广。
目的：觀察腎康註射液治療慢性腎功能衰竭( CRF )併腎性貧血的臨床療效。方法將60例慢性腎功能衰竭併腎性貧血患者隨機分為治療組和對照組，各30例，均給予重組人促紅細胞生成素（rHuEPO）註射液及口服鐵劑等治療，治療組加用腎康註射液。觀察兩組治療前後血紅蛋白（Hb）、血細胞比容（Hct）、血清肌酐（SCr）、血尿素氮（BUN）等指標的變化情況。結果治療組的腎性貧血和腎功能指標改善均明顯優于對照組（ P＜0.05）。結論腎康註射液治療慢性腎功能衰竭併腎性貧血，療效顯著，值得臨床推廣。
목적：관찰신강주사액치료만성신공능쇠갈( CRF )병신성빈혈적림상료효。방법장60례만성신공능쇠갈병신성빈혈환자수궤분위치료조화대조조，각30례，균급여중조인촉홍세포생성소（rHuEPO）주사액급구복철제등치료，치료조가용신강주사액。관찰량조치료전후혈홍단백（Hb）、혈세포비용（Hct）、혈청기항（SCr）、혈뇨소담（BUN）등지표적변화정황。결과치료조적신성빈혈화신공능지표개선균명현우우대조조（ P＜0.05）。결론신강주사액치료만성신공능쇠갈병신성빈혈，료효현저，치득림상추엄。
Objective To observe the clinical efficacy of Shenkang Injection in the adjuvant treatment of chronic renal failure ( CRF ) and renal anemia. Methods Totally 60 patients with chronic renal failure and renal anemia were randomly divided into the treatment group and the control group,30 cases in each group. The two groups were treated with Recombinant Human Erythropoietin(rHuEPO)Injection and oral iron preparation. In addition the observation group was added with Shenkang Injection. The change situation of hemoglobin (Hb),hematocrit(Hct),serum creatinine(SCr),blood urea nitrogen(BUN) before and after treatment was observed in the two groups. Results The improvement of renal anemia and renal function in the observation group was significantly superior that in the control group( P < 0. 05). Conclusion Shenkang Iinjection has remarkable effect in treating chronic renal failure and renal anemia and deserves clinical promotion.
